Back to companies
Protalix BioTherapeutics, Inc.
PLXUSNYSEPharmaceuticals & HealthcareProtalix BioTherapeutics, Inc.
Revenue
$52.7mn
YoY -1.2%
Operating income
-$5.5mn
FY2025
Employees
—
Founded
—
Source: U.S. Securities and Exchange Commission (SEC) EDGAR Company Facts API